Challenges and optimisation strategies for nuclear medicine and radiopharmacy in a crisis such as the COVID-19 pandemic and Brexit

Author(s): Busola Ade-Ojo, Dr Ewa Nowosinska, Rohit Tiwari

Hospital: Barts Health NHS Trust

Reference: RAD Magazine, 48, 565, 19-21


The coronavirus pandemic (COVID-19) caused significant disruption to healthcare all over the world and interrupted patient care and service delivery. Limited access to healthcare, primarily to imaging services caused by cancellations and disruption to outpatient services due to extended lockdowns and travel restrictions, meant that the impact on patient care went beyond a diagnostic test. Additionally, patients often had increased waiting times for their diagnostic imaging tests due to new restrictions on patient throughput, infection control procedures and workforce pressures

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more